
Dybito MV 1mg/500mg/0.3mg Tablet
Marketer
Avail Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Dybito MV 1mg/500mg/0.3mg Tablet
Combiflex-DM, a triple-combination antidiabetic medication (1mg/500mg/0.3mg), manages type 2 diabetes in adults by regulating blood glucose. Administer this tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial; abrupt cessation without medical supervision can lead to elevated blood sugar, increasing the risk of nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, cephalalgia, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Primary Ingredients of Dybito MV 1mg/500mg/0.3mg Tablet
No text provided. Please provide the text you wish to be rephrased.
Uses of Dybito MV 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Dybito MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Dybito MV 1mg/500mg/0.3mg tablets should be administered on an empty stomach.
Common Side effects of Dybito MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Dybito MV 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Dybito MV 1mg/500mg/0.3mg tablet whole; avoid chewing, crushing, or fracturing. Consumption should occur on an empty stomach.
How Dybito MV 1mg/500mg/0.3mg Tablet works:
Dybito MV tablets, containing 1mg, 500mg, and 0.3mg of three distinct antidiabetic agents, offer a triple-action approach to blood sugar management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dybito MV 1mg/500mg/0.3mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dybito MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Employing Dybito MV 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dybito MV 1mg/500mg/0.3mg tablets is inadvisable for individuals with kidney impairment and should be forgone. Medical advice is essential. Specifically, this medication is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Individuals with liver impairment should use Dybito MV 1mg/500mg/0.3mg tablets cautiously. Dosage modifications may be necessary. Physician consultation is advised. A reduced initial dose is typically prescribed for patients with mild to moderate liver disease; the medication is contraindicated in those with severe liver dysfunction.
What if you forget to take Dybito MV 1mg/500mg/0.3mg Tablet :
Should you forget to take a Dybito MV 1mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dybito MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
